 |
|
|
| |
HCV ERADICATION RESULTS IN REDUCTION OF HEPATIC VENOUS PRESSURE GRADIENT 48 WEEKS AFTER END OF TREATMENT; FINAL RESULTS OF THE STUDY OF SOFOSBUVIR PLUS RIBAVIRIN IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION
|
| |
| |
Reported by Jules Levin
EASL 2016 April 14-17 Barcelona
Nezam Afdhal* 1, Tarik Asselah2, Gregory T. Everson3, Jaime Bosch4, Shampa De-Oertel5, Diana M. Brainard5, John G. McHutchison5, Yin Yang5, Kymberly D. Watt6, Michael Curry1, Edward Gane7
1Beth Israel Deaconess Medical Center, Boston, MA, United States, 2Hopital Beaujon, INSERM UMR 1149 and University of Paris-Diderot, Clichy, France, 3University of Colorado, Denver, Aurora, CO, United States, 4Liver Unit, IDIBAPS, CIBEREHD, Barcelona, Spain, 5GILEAD SCIENCES, INC, Foster City, CA, 6Mayo Clinic, Rochester, MN, United States, 7University of Auckland, Auckland, New Zealand
|
| |
|
|
|
|
|
